Foghorn Therapeutics Inc. (FHTX) Tops Q1 EPS by 3c

Foghorn Therapeutics Inc. (NASDAQ: FHTX) reported Q1 EPS of ($0.59), $0.03 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $5.1 million versus the consensus estimate of $6.86 million.

For earnings history and earnings-related data on Foghorn Therapeutics Inc. (FHTX) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Mizuho Resumes Spire (SR) at Outperform
• Intercontinental Exchange (ICE) PT Lowered to $208 at Raymond James, 'we view the risk/reward as attractive'